Form 4 for CRL Charles River Laboratories
Accepted 2025-02-21 00:00:00 ET · period of report 2025-02-20 · accession 0001127602-25-006249 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-21 | 2025-02-20 | CRL | LaPlume Joseph W | EVP, Corp Strategy, Develop | S - Sale | $162.50 | -4,400 | 20.0K | -18% | -$715.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-20 | S | D | 4,400 | $162.50 | 20,013 | D | — | — |